Loading...
Original Publication Date
2026
Document Type
Video
Abstract
Opioids are widely used to treat moderate to severe pain, but chronic use often leads to tolerance, requiring escalating doses that increase the risk of dependence, respiratory depression, and overdose. One contributing factor to opioid tolerance is disruption of gut barrier integrity, which can cause inflammation and systemic physiological effects. This study investigates whether broccoli-derived compounds can mitigate opioid tolerance by protecting gut health. Broccoli contains glucoraphanin, which is converted into the bioactive compound sulforaphane, known for its anti-inflammatory properties and ability to support gut barrier integrity and microbiome balance. Using both animal models and intestinal cell line experiments, this research examined the effects of broccoli seed extract on morphine tolerance and gut inflammation. In mice chronically treated with morphine, co-administration of broccoli seed extract improved responsiveness to morphine in a tail-flick pain assay, suggesting reduced tolerance. Complementary cell culture experiments showed that colon-conditioned media from morphine-treated animals increased IL-8 expression in intestinal cells, whereas broccoli seed extract significantly reduced this inflammatory response. These findings suggest that sulforaphane may help preserve gut barrier function, reduce inflammation, and enhance opioid analgesic effectiveness. Broccoli-derived compounds, therefore, show promise as a potential therapeutic strategy to reduce opioid tolerance and improve pain management outcomes.
Keywords
Opioid tolerance, Morphine, Broccoli seed extract, IL-8 inflammation
Rights
Copyright © 2026 Atharv Ashwin Battu. All rights reserved.
Comments
Presented in the New Frontiers in Detecting Disease and Managing Pain session